Matinas Biopharma Hl (MTNB) Recent Earnings

Matinas Biopharma Hl (MTNB) reported a Quarter December 2025 loss of $0.26 per share on revenue of $0.0 million..

Matinas BioPharma Holdings Inc is a biopharmaceutical company. The Company is engaged in identifying & developing novel pharmaceutical products for the treatment of abnormalities in blood lipids, & the treatment of cardiovascular disease.